SIA "InPharma"Active

40103280398Limited liability companyFounded 2010

Key figures

79 538 €+49,3%
Revenue 2025
+5,1%
Average annual growth 2010–2025
025 k50 k75 k100 k’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
050 k100 k’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

Paid out in dividends approximately 23 804 € (83% of equity at the end of the previous year).

Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).

History
2025 ~23 804 €
2024 ~21 035 €
2023 ~24 999 €
2022 ~26 367 €
2021 ~37 500 €
2020 ~29 058 €
20190 €
20180 €
20170 €
2016 ~49 498 €
20150 €
20140 €
2013 ~41 793 €
20120 €
20110 €
Summary of financial statements2010–2025
2010201120122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets21 58633 80242 44815 85039 22355 90921 42124 62920 69436 65033 79046 50347 41031 96827 32426 830
Total non-current assets674149792775122149511471937264528202146 54437 97830 08918 65783141015
Total assets28 32738 78145 22317 07144 17457 38022 35824 89321 22238 67180 33484 48177 49950 62535 63827 845
Balance sheet — liabilities and equity
Current liabilities7837876114303594631850365340338712 1913587493619 62711 80711 37567884475
Non-current liabilities000000256300024 25610 3644699000
Total liabilities7837876114303594631850367903338712 191358729 19229 99116 50611 37567884475
Share capital————————————————
Retained earnings of previous periods————————————————
Profit for the year18 490961513 77311 47722 43414 39011 6097051-12 44145 21445 11640 84832 870325610 63518 324
Total equity20 49030 02043 79313 47737 85652 34414 45521 506903135 08451 14254 49060 99339 25028 85023 370
Income statement
Sales revenue37 57253 36256 47462 23991 63983 68586 11176 58876 80077 44177 77789 79576 42149 22153 28279 538
Operating profit21 59710 52113 69112 53222 44821 90111 7258231-12 44153 87945 32841 37733 167396411 59420 525
Profit before income tax21 555961513 77311 47722 43421 92211 6097051-12 44153 87045 11640 84832 870325610 63520 525
Profit for the reporting year18 490961513 77311 47722 43414 39011 6097051-12 44145 21445 11640 84832 870325610 63518 324
Labour costs————————————————
Depreciation of non-current assets————————————————
Other indicators
Employees1114445551111111
Calculated dividend—0041 7930049 49800029 05837 50026 36724 99921 03523 804

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
100%SIA "InPharma"Freimane Inta
CompanyPersonShareholderOther roleAdditional link

Summary: SIA "InPharma"

Overview

SIA "InPharma" (reg. no. 40103280398) is a limited liability company. The company was registered in 2010 and has been in the register for 16 years. Registered address: Rīga, Buļļu iela 62A - 2.

Financial results

Revenue in 2025 was 79 538 €, up 49,3% on the previous year (53 282 €). From 2010 to 2025, revenue grew by an average of 5,1% per year. Net profit for 2025 was 18 324 € (23,0% of revenue). The company was profitable in 15 of the 16 published years. In 2025 the company had 1 employees. Revenue per employee was 79 538 €. At the end of 2025, total assets were 27 845 € and equity 23 370 € (83,9% of assets).

Management and owners

The company has one board member. The sole owner of the company is a private individual.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.